Norfenazin

Quick links to important sections

Norfenazin

Method of action: Antidepressant, Psychoanaleptics

Treatment option: Depression

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Norfenazin

Property Description
Active Ingredient Nortriptyline Hydrochloride
Form Capsules, tablets, oral solution
Pharmacological Class Tricyclic Antidepressant (TCA)
Common Use Supports nervous system balance and mood regulation
Origin Synthetic, secondary amine derivative

What is Norfenazin and Its Chemical Identity?

Norfenazin is a prescription-only medication whose active component is the single substance Nortriptyline Hydrochloride. This substance is the stable hydrochloride salt of Nortriptyline and is classified as a synthetic compound. Structurally, it is recognized as a secondary amine within the dibenzocycloheptadiene chemical family. This chemical profile confirms Nortriptyline's relationship to Amitriptyline, as Nortriptyline is known to be the active metabolite of Amitriptyline.


Pharmacological Class and General Purpose

Norfenazin belongs to the Tricyclic Antidepressant (TCA) group, establishing it as a member of the first-generation antidepressants class. Its general purpose is rooted in its ability to support the central nervous system in correcting imbalances related to mood and nervous system function. The medication is identified as a potent inhibitor of norepinephrine reuptake and a moderate inhibitor of serotonin reuptake. This function means the medicine primarily helps nerve cells maintain a balanced level of these crucial chemical messengers, a principle that is clinically recognized for mood stabilization.


Available Forms and Administration Type

The active substance, Nortriptyline Hydrochloride, is manufactured for controlled delivery and is available for oral administration in several standard pharmaceutical preparations. These include hard capsules, film-coated tablets, and an oral solution. These various oral dosage forms ensure that the medication is designed to achieve systemic absorption, allowing the active ingredient to enter the bloodstream and maintain the necessary concentrations for its intended effect in the central nervous system.

Regulatory References

  1. Tricyclic Antidepressant (TCA)
  2. first-generation antidepressants
  3. norepinephrine reuptake
  4. serotonin reuptake
  5. systemic absorption

What side effects are possible with Norfenazin?

Possible Side Effects and Safety Information

The safety profile for Norfenazin (Nortriptyline) is defined by official regulatory documents, which classify adverse reactions according to the physiological system affected and their reported frequency.

Frequency-Classified Adverse Reactions

The most frequently documented effects are classified as Very Common (affecting more than 1 in 10 individuals). These primarily include dry mouth, constipation, nausea, tremor, dizziness, and headache. Cardiovascular effects such as tachycardia (fast heart rate), palpitation, and orthostatic hypotension (low blood pressure upon standing) are also listed as Very Common. Common reactions often affect Psychiatric Disorders, while Rare effects may include certain blood and lymphatic system disorders, such as agranulocytosis.


Serious Safety Considerations

Official labeling highlights the potential for serious adverse reactions affecting major organ systems. These include serious cardiac events such as myocardial infarction, strokes, and arrhythmia. The risk of suicidal thoughts and behaviors is noted, particularly in young adults and during the initial few months of therapy or following dose changes. Serotonin Syndrome is a risk when used with certain other medications.


Population-Specific Safety Notes

Regulatory documents include specific safety statements for certain groups. Older adults are particularly susceptible to certain adverse reactions, including agitation, confusion, and postural hypotension. The medication is noted to lower the convulsive threshold, requiring caution in individuals with a history of seizures. Furthermore, caution is advised for patients with pre-existing conditions like narrow-angle glaucoma or cardiovascular disease.

Overdose and Emergency Response

Overdose Manifestations and Life-Threatening Outcomes

The official regulatory profile for Norfenazin (Nortriptyline) overdose documents severe toxicity primarily affecting the Cardiovascular System and the Central Nervous System (CNS). CNS disturbances can rapidly progress from confusion, agitation, and hallucinations to seizures and coma. Anticholinergic signs, such as dilated pupils (mydriasis) and urinary retention, are also documented. Cardiovascular crisis is a key concern, presenting with severe and potentially life-threatening abnormal heart rhythms (arrhythmia), tachycardia, and severe low blood pressure (hypotension). Regulatory information confirms that fatalities have occurred following overdose.


Mandatory Emergency Actions and Management

The regulatory mandate is to seek immediate medical attention or contact a certified Poison Control Center or emergency room immediately. This urgent action is required upon suspicion of overdose, even if symptoms are not yet apparent, due to the potential for rapid escalation of severity. As no specific antidote is known, management is strictly symptomatic and supportive. The official documentation specifies that patients require continuous ECG monitoring due to the significant risk of cardiac complications, along with close observation of vital signs and airway management.

Therapeutic Uses of Norfenazin

What Norfenazin Treats: Main Uses and Benefits

Norfenazin (Nortriptyline) is commonly used to help with symptoms related to systemic imbalance across therapeutic areas such as managing affective symptoms and persistent physical discomfort. The medication is relevant in contexts involving heightened systemic burden and is commonly used to help with symptoms that interfere with daily functioning in the context of depression. The medication is considered relevant in managing symptom-driven clinical presentations such as Major Depressive Disorder, chronic neuropathic pain, and migraine prophylaxis.

This medicine is considered relevant in situations involving certain distressing symptoms that create noticeable physiological strain. It helps address symptom clusters that may become intense or disruptive, such as a persistently low mood, shooting nerve pain, or associated sleep disruption. The medication may assist with maintaining functional stability, which contributes to easing the overall symptom load.

Quick Fact: Management of Chronic Pain Norfenazin plays a role in managing symptoms of increased neurological activity, which is applied in addressing chronic discomfort like postherpetic neuralgia. It supports patients during episodes of heightened discomfort by easing symptom intensity.

Regulatory References

  1. U.S. National Library of Medicine MedlinePlus overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Norfenazin?

Norfenazin (Nortriptyline) eligibility is strictly defined by regulatory documents, excluding certain populations due to its Tricyclic Antidepressant (TCA) classification and established risks. Use is primarily restricted to adults.


Contraindicated Populations

Use of Norfenazin is absolutely contraindicated in patients in the acute recovery period following a Myocardial Infarction (MI) and in those concurrently taking a Monoamine Oxidase Inhibitor (MAOI). It is also contraindicated for individuals with known hypersensitivity to Nortriptyline Hydrochloride. Some regulatory labels additionally contraindicate use in patients with pre-existing heart block or severe cardiac arrhythmias.


Age-Related Eligibility and Restrictions

Age Group Regulatory Status
Children and Adolescents (< 18 years) Not Recommended. Safety and efficacy have not been established.
Adults (> 18 years) Approved population for labeled indications.
Older Adults (Geriatric) Use is permitted, but lower dosages are often recommended for initiation.

Condition-Specific Limitations

Use with caution is mandated for patients with pre-existing conditions such as narrow-angle glaucoma, a history of seizures or epilepsy, and those with hyperthyroidism. Patients with advanced hepatic impairment require careful, supervised dosing. Safe use has not been established for women during pregnancy or lactation, requiring careful assessment of potential hazards versus benefits.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Norfenazin (Nortriptyline) is defined by mandatory prohibitions and rules regarding metabolic competition and additive effects, strictly as documented by regulatory authorities.


Prohibited Combinations and Timing Rules

Co-administration is formally contraindicated with Monoamine Oxidase Inhibitors (MAOIs), including agents with MAOI activity such as Linezolid and Intravenous Methylene Blue. These combinations carry a high risk of adverse reactions, including Serotonin Syndrome. A mandatory wash-out period of at least two weeks is required when switching between Norfenazin and an MAOI. Furthermore, a separation period of at least five weeks should elapse when switching from Fluoxetine to Norfenazin, due to the long half-life of Fluoxetine.


Pharmacokinetic and Pharmacodynamic Effects

Norfenazin is metabolized by the Cytochrome P450 2D6 (CYP2D6) enzyme. Co-administration with strong CYP2D6 inhibitors, including Cimetidine and Quinidine, causes a clinically significant increase in Norfenazin's systemic plasma concentration. Pharmacodynamic interactions occur with Alcohol (Ethanol) and Other CNS Depressants, resulting in a documented additive effect and worsened sedative outcomes. The drug will also block the hypotensive actions of agents like Guanethidine. Tobacco Smoking may increase the clearance of the drug, and co-administration with St. John's Wort is documented to increase the risk of side effects. Individuals identified as CYP2D6 Poor Metabolizers naturally exhibit higher expected drug concentrations at standard doses.

Mechanism of Action

Nortriptyline Hydrochloride modulates neurotransmitter dynamics and engages in broad receptor antagonism, resulting in defined physiological adjustments. The drug's primary action is the high-affinity inhibition of the Norepinephrine Transporter ( NET) and moderate inhibition of the Serotonin Transporter ( SERT). By blocking these molecular structures, the concentration and dwelling time of norepinephrine and serotonin are increased in the synaptic cleft . This sustained elevation initiates a cascade of neuroplastic adaptation, including receptor down-regulation and modulation of Brain-Derived Neurotrophic Factor ( BDNF), which establishes a long-term alteration in central neurotransmission. Furthermore, Nortriptyline acts as an antagonist across several secondary receptor systems, notably the Histamine H1 receptors and Muscarinic Acetylcholine receptors ( mAChRs). This non-selective action shapes the physiological outcome by dampening H1- and cholinergic-mediated signaling across central and peripheral pathways. The antagonism of alpha1-Adrenoceptors further modulates autonomic regulation, specifically interfering with processes that govern vascular tone.

Dosage and Administration Information

How to Use Norfenazin

Norfenazin (Nortriptyline Hydrochloride) is administered strictly via the oral route, utilizing dosage forms such as capsules, tablets, and an oral solution. The official usage protocol is structured around a precise system of initiation, maintenance, and discontinuation.


Official Administration Guidelines

Property Instruction
Route of Administration Oral (capsules, tablets, or solution).
Dosing Schedule Therapy begins at a low level and is gradually increased. The standard adult daily dose is often initiated at 25 mg two to four times daily. The established maximum recommended dose for outpatients is 150 mg per day.
Frequency Pattern The total daily dose may be administered in divided use (multiple times per day) or as a single dose once a day, typically taken at bedtime.
Population Adjustments Lower dosages are mandated for specific populations, including older adults and adolescents, where the typical daily dose ranges from 30 mg to 50 mg.
Timing and Preparation The medication may be taken with or without food. When using the oral solution, an accurate measuring device must be used for administration.

Course Management and Monitoring

The usage protocol defines a period of treatment that extends beyond the acute phase, often continuing for up to six months after recovery to help prevent relapse. For doses exceeding 100 mg per day, the official protocol requires plasma level monitoring to maintain the necessary systemic concentration. Furthermore, the instructions specify that therapy must be gradually tapered over several weeks when discontinuation is intended, rather than being stopped abruptly.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Norfenazin

Research Evidence for Major Depressive Disorder (MDD)

Norfenazin (Nortriptyline) was studied in research examining symptom patterns in individuals with Major Depressive Disorder in numerous Randomized Controlled Trials (RCTs) and comprehensive meta-analyses. These studies were applied in research examining patient-reported experiences in both adults and adolescents with MDD.

Research examined key clinical outcomes, including changes measured on standardized depression rating scales and rates of symptom clearance (remission). Findings describe patterns observed in the studies related to short-term symptom changes over the typical 4- to 12-week study duration. The full nature of long-term outcomes beyond six months remains to be fully established by the existing research.


Studies Investigating Chronic Neuropathic Pain

The compound was also studied in research contexts focusing on chronic neuropathic pain conditions, such as postherpetic neuralgia. The evidence consists primarily of Randomized Controlled Trials and subsequent systematic reviews that studied the agent in adults with specific neuropathic pain conditions.

Research measured patient-reported outcomes describing perceived discomfort, specifically tracking changes in pain intensity and changes in daily functioning. Findings describe patterns observed in the studies, but the certainty of the evidence is considered low in some systematic reviews, as many trials had sample sizes that were modest.


Research on Migraine Prophylaxis and Other Uses

Research has also explored Norfenazin's application in migraine symptom management trials, relevant in trials assessing episodic or acute changes. The evidence in this area includes medium-term RCTs that tracked changes in the frequency and intensity of headache episodes. The agent has been referenced in authoritative clinical guidelines.

Research has also explored the compound in studies monitoring smoking abstinence. Findings indicate that prolonged abstinence was observed in some studies, and studies described patterns where the number of people remaining abstinent decreased over time in the treatment group.


What is Still Uncertain About Norfenazin Research

Research provides context but does not determine whether an individual will respond similarly, as study results reflect the specific conditions under which they were conducted. Several areas of uncertainty exist in the current evidence landscape, including limited information for long-term outcomes for most non-MDD indications, meaning long-term effects are not fully established. Additionally, comparative evidence is lacking in some areas to fully understand how Norfenazin’s patterns of change differ from all other available compounds.

Key Studies & References

  1. Nortriptyline: U.S. National Library of Medicine MedlinePlus Overview
  2. Nortriptyline Hydrochloride DailyMed Monograph

Frequently Asked Questions (FAQ)

Common questions about Norfenazin (FAQ)


Q: How quickly does Norfenazin typically start to work?

According to official patient information, initial symptom benefits may be observed within two weeks of starting the medication. However, it can often take up to two full months for the therapeutic changes to be observed in clinical patterns.


Q: How long can a person stay on Norfenazin?

Official usage protocol defines a period of treatment that often continues for up to six months following recovery for management purposes. This duration is defined to support continued stability after the acute phase of symptoms.


Q: Does Norfenazin cause weight gain?

Regulatory documents list changes in weight as a possible adverse reaction associated with Norfenazin. Both weight gain and weight loss are reported in official side effect listings.


Q: What happens if I forget to take my dose of Norfenazin?

Patient information describes a protocol where, if a single daily dose is typically taken at bedtime and is missed, the recommended action is often to wait until the next scheduled dose. Specific instructions for a missed dose vary based on the prescribed schedule.


Q: Is Norfenazin considered habit-forming or addictive?

Official safety documentation explicitly states that while stopping the medication abruptly can cause certain physical reactions (such as nausea and headache), these effects are not considered indicative of addiction. The drug is not classified as a controlled substance.


Q: Can Norfenazin affect my mood or energy levels?

The medication's purpose relates to nervous system balance and mood regulation. However, official safety information includes warnings about the emergence of certain behavioral and emotional changes such as anxiety, agitation, and mania. These reactions are noted especially during the initial phase of treatment or following dose changes.


Q: What kind of foods or drinks should I avoid while taking Norfenazin?

Regulatory warnings specifically cite an interaction with Alcohol (Ethanol). Regulatory warnings describe that combining the medication with alcohol has a documented additive effect, which is associated with worsened sedative outcomes like drowsiness.


Q: Can Norfenazin be taken while breastfeeding?

The active ingredient in Norfenazin is known to be excreted into human milk. Due to this transfer, regulatory guidance states that safe use has not been established for women during the period of lactation, and the potential effects on a nursing infant are noted as unknown.


Q: What is the general long-term expectation for someone using Norfenazin?

Studies and official information indicate that the full nature of long-term outcomes beyond six months, particularly for non-Major Depressive Disorder indications, remains to be fully established by existing research. Study results reflect the specific conditions under which they were conducted.


Q: Can Norfenazin cause problems with driving or operating machinery?

Official safety information includes a warning that the medication may impair the mental and/or physical abilities required for performing hazardous tasks, such as operating complex machinery or driving a motor vehicle. This is due to potential effects like dizziness or sedation.


Q: What is the half-life of Norfenazin?

The half-life refers to the time it takes for half of the active substance to be cleared from the bloodstream. Official pharmacokinetic data indicates that the plasma half-life of the active ingredient, Nortriptyline, is documented to range from 16 to more than 90 hours.


Q: Does taking Norfenazin mean I have to limit my sun exposure?

Some official reports note that an adverse reaction to the medication may include an increased sensitivity of the eyes or skin to light. In some documented instances, this has resulted in severe sunburn. This effect may indicate a need for caution regarding sun exposure.


Q: Is it okay to stop Norfenazin suddenly if I feel better?

Official instructions describe that discontinuation is protocolized by gradually tapering the dosage over several weeks. Abrupt cessation is not recommended because it can produce withdrawal symptoms such as nausea, headache, and a general feeling of being unwell.


Q: Are there any specific monitoring tests needed while on Norfenazin?

Official protocols specify that patients taking high doses (over 100 mg per day) may require plasma level monitoring. Additionally, close monitoring of cardiovascular function and ECG (electrocardiogram) changes may be required.


Q: Why do official sources list so many potential side effects?

Regulatory agencies mandate comprehensive disclosure. Official documents classify and list all documented adverse reactions based on how often they have been reported during clinical trials or post-marketing surveillance. This ensures patients receive a complete disclosure of potential effects, regardless of how common or rare they are.

How should Norfenazin be stored and disposed of?

Norfenazin (Nortriptyline Hydrochloride) must be stored under specific conditions to maintain its effectiveness and ensure safety.

Storage Requirements

Condition Requirement
Temperature Store at 20 C to 25 C (68 F to 77 F) (Controlled Room Temperature).
Protection Keep away from excess heat and moisture; avoid storing in the bathroom.
Container Keep the medication in the original container, tightly closed, with a child-resistant closure.
Child Safety Must be kept out of the sight and reach of children in a secure location, with safety caps locked.

Disposal Instructions

Do not flush Norfenazin down the toilet or throw it in the trash directly. The preferred method for disposal is using a local drug take-back program. If a take-back program is unavailable, unused medication should be mixed with an undesirable substance (like coffee grounds or dirt), sealed in a plastic bag or container, and discarded in the household trash. All disposal must follow local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Norfenazin found in:

A-Z Index: